[Pancytopenia after viral infection in St. n. malignant lymphoma].
Seifert
B
B
Medizinische Universitätspoliklinik, Departement Innere Medizin, Kantonsspital Basel.
Favre
G
G
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000175:diagnosis; D009367:Neoplasm Staging; D009894:Opportunistic Infections / Q000209:etiology*; D010198:Pancytopenia / Q000139:chemically induced* / Q000175:diagnosis; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects*; D012141:Respiratory Tract Infections / Q000209:etiology*; D033581:Stem Cell Transplantation; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone